Catalyst Pharm Inc (CPRX)
$3.68 0.28 (7.07%)
19:34 EST CPRX Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 377.55M
PE Ratio -17.52
Volume (Avg. Vol.) 1.75M
Day's Range 3.67 - 3.96
52-Week Range 2.55 - 5.19
Dividend & Yield N/A (N/A)
CPRX Stock Predictions, Articles, and Catalyst Pharm Inc News
- From InvestorPlace
- From the Web
Penny stocks are low price for a reason. Most presume they're destined for bankruptcy. But these seven may survive: they actually make money.
Catalyst Pharmaceuticals stock has been on a wild ride since its drug got FDA approval -- and despite legal drama, it may be worth the risk.
Typically, a major clinical victory would boost names like Catalyst Pharmaceuticals stock. Unfortunately, some political rumblings and an unexpected competitor got in the way of CPRX.
These biotech stocks have fast-approaching PDUFA dates. Biotechs can soar or plunge on FDA decisions. These four pharma stocks should soar.
The overall ratings of 23 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Now on the horizon: The ECB, payrolls and Friday's showdown between President Obama and congressional leaders.
Investors have been chasing risk again, buying up biotech stocks. Here's our list of the best biotech stocks out there.
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader